![Hongming Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hongming Chen
Founder at
METIS TECHBIO CO., LTD.
Net worth: 152 M $ as of 2026-09-29
Profile
Hongming Chen was the founder of Kala Bio, Inc., founded in 2010, serving as Chief Scientific Officer.
Dr. Chen is the founder of METiS Therapeutics, Inc., founded in 2022, serving as President & Head-Research & Development.
Dr. Chen is the founder of Metis TechBio Co., Ltd., founded in 2020, serving as Director, Chief Research & Development Officer.
Dr. Chen is currently a Member at the National Academy of Engineering.
Former jobs include Director-Formulation Development at TransForm Pharmaceuticals, Inc. from 2000 to 2010, Senior Process Engineer at Merck & Co., Inc. in 1997, and Scientist at AstraZeneca PLC in 2000.
Education includes an undergraduate degree from The University of Texas at Austin in 1992, a graduate degree from Massachusetts Institute of Technology in 1995, and a doctorate from Massachusetts Institute of Technology in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-09 | 46,839,443 ( 4.32% ) | 107 M $ | 2026-09-29 | |
METIS TECHBIO CO., LTD. 20.16% | 2026-05-12 | 20,074,047 ( 20.16% ) | 46 M $ | 2026-09-29 |
Hongming Chen active positions
| Companies | Position | Start |
|---|---|---|
| METIS TECHBIO CO., LTD. | Founder | 2020-01-09 |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Founder | - |
Former positions of Hongming Chen
| Companies | Position | End |
|---|---|---|
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 2009-12-31 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 1999-12-31 |
| MERCK & CO., INC. | Corporate Officer/Principal | 1996-12-31 |
| KALA BIO, INC. | Founder | - |
Education of Hongming Chen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
- Stock Market
- Insiders
- Hongming Chen
